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doi:10.1016/j.jtcvs.2005.11.037ackground: Autologous recellularization of decellularized heart valve scaffolds is
promising challenge in the field of tissue-engineered heart valves and could be
oosted by bone marrow progenitor cell mobilization. The aim of this study was to
xamine the spontaneous in vivo recolonization potential of xenogeneic decellular-
zed heart valves in a lamb model and the effects of granulocyte colony-stimulating
actor mobilization of bone marrow cells on this process.
ethods: Decellularized porcine aortic valves were implanted in 12 lambs. Six
ambs received granulocyte colony-stimulating factor (10 g · kg1 · d1 for 7
ays, granulocyte colony-stimulating factor group), and 6 received no granulocyte
olony-stimulating factor (control group). Additionally, nondecellularized porcine
alves were implanted in 5 lambs (xenograft group). Angiographic and histologic
valuation was performed at 3, 6, 8, and 16 weeks.
esults: Few macroscopic modifications of leaflets and the aortic wall were ob-
erved in the control group, whereas progressive shrinkage and thickening of the
eaflets appeared in the granulocyte colony-stimulating factor and xenograft groups.
n the 3 groups progressive ovine cell infiltration (fluorescence in situ hybridization)
as observed in the leaflets and in the adventitia and the intima of the aortic wall
ut not in the media. Neointimal proliferation of -actin–positive cells, inflamma-
ory infiltration, adventitial neovascularization, and calcifications were more impor-
ant in the xenograft and the granulocyte colony-stimulating factor groups than in
he control group. Continuous re-endothelialization appeared only in the control
roup.
onclusion: Decellularized xenogeneic heart valve scaffolds allowed partial auto-
ogous recellularization. Granulocyte colony-stimulating factor led to accelerated
eart valve deterioration similar to that observed in nondecellularized xenogeneic
ardiac bioprostheses.
linically available cardiac valve prostheses have long-term limitations, in-
cluding the need for lifelong anticoagulation for mechanical prosthesis and
limited durability for bioprostheses.1 Tissue engineering could create andeal valve, with physiologic hemodynamic behavior, low immunogenic potential,
The Journal of Thoracic and Cardiovascular Surgery ● Volume 131, Number 4 843
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ETnd repair, remodeling, and growing capabilities. Several
roups demonstrated the feasibility of creating living valves
n vitro through seeding autologous cells on various scaf-
olds, such as synthetic polymers, collagen, and allogeneic
r xenogeneic valve conduits.2-4 Xenogeneic natural scaf-
olds have the advantage of adequate anatomic structure and
nlimited availability. However, they can trigger deleterious
mmune responses, especially cell-mediated ones. Decellu-
arization of xenogeneic valve matrices reduces their anti-
enicity, and recent in vitro studies suggest that decellular-
zed porcine valve matrices are a suitable scaffold for
ecolonization by smooth muscle cells.5
The strategy to promote the recolonizing process re-
ains questionable. First experiments were conducted
ith differentiated vascular cells (endothelial cells or
mooth muscle cells) obtained from samples of saphe-
ous veins or autologous carotid arteries.2,6 More re-
ently, bone marrow (BM) cells have been demonstrated
o contain various progenitor cells, such as endothelial
rogenitors and mesenchymal lineage cells, which can
nduce tissue regeneration when injected into cardiovas-
ular structures.7 Cardiac valve interstitial cells are myo-
broblasts of mesenchymal origin, and it was demon-
trated that BM cells could recolonize synthetic valve
caffolds in vitro, thus confirming that BM cells contain
roper cell progenitors for heart valve reconstruction.8,9
Early BM progenitor cells can be mobilized by growth
actors, such as granulocyte colony-stimulating factor
G-CSF), into peripheral blood. Numerous experimental
tudies have shown that G-CSF–mobilized BM cells are
ble to home to injured cardiovascular tissues and contrib-
te to tissue regeneration, especially in infarcted myocar-
ium and hind-limb ischemic areas.10,11
The aim of this study was to examine the spontaneous in
ivo recolonization potential of xenogeneic decellularized
eart valves in a lamb model and the effects of G-CSF
obilization of BM cells on this process.
ethods
ampling and Decellularization of Porcine
ortic Valves
ortic valve conduits were sampled from pigs (Large white/
andras, 10-15 kg of body weight). The animals were anesthetized
y means of intravenous injection of propofol, 20 mg/kg, and
ufentanil, 1 g/kg. After median sternotomy, the heart was ex-
lanted under surgical conditions. Aortic valve conduits were har-
ested with a thin ridge of subvalvular muscle tissue proximally
Abbreviations and Acronyms
BM  bone marrow
G-CSF granulocyte colony-stimulating factor
VWF  Von Willebrand Factornd a short arterial segment distally. Then porcine valve conduits d
44 The Journal of Thoracic and Cardiovascular Surgery ● Apriere calibrated with a Hegar dilatator, weighed, and washed
n Hank’s balanced salt solution plus aprotinin (10 KIU/mL),
enicillin (100 U/mL), streptomycin (100 g/mL), and nystatin
100 U/mL) plus N-2-hydroxyethylpiperazine-N-2-ethanesulfonic
cid (10 mmol/L) at pH 7.6. Valve conduits were decellularized
hrough a nonenzymatic procedure, associating hypotonic shock
nd low-concentration ionic detergent, as previously described. 12,13
riefly, valve conduits were incubated at 20°C during constant
tirring in hypotonic buffer (Tris, 10 mmol/L; ethylendiamine
etraacetic acid, 0.1%; and aprotinin, 10 KIU/mL; pH 8) for 14
ours and hypotonic buffer with sodium dodecylsulfate (0.1%) for
4 hours, washed in isotonic buffer (Tris, 50 mmol/L; NaCl, 0.15
ol/L; ethylendiamine tetraacetic acid, 0.1%; aprotinin, 10 KIU/
L; pH 8) for 24 hours, and then immediately implanted in lambs.
oreover, additional porcine valve conduits were sampled and stored
n Hank’s balanced salt solution plus aprotinin (10 KIU/mL),
enicillin (100 U/mL), streptomycin (100 g/mL), and nystatin
100 U/mL) plus N-2-hydroxyethylpiperazine-N-2-ethanesulfonic
cid (10 mmol/L) at pH 7.6 for 72 hours at room temperature
ithout any decellularization process. In all valves sterility con-
rols were realized on the last washing solution.
tudy Design
n 17 lambs (Romanov/Ile de France; aged 12-16 weeks; median
eight, 23 kg) a porcine aortic valve conduit was implanted in the
escending thoracic aorta. Five lambs received a nondecellular-
zed porcine valve (xenograft group). Twelve lambs received a
ecellularized porcine valve. Among them, 6 received subcu-
aneous injections of G-CSF (Neupogen, a kind gift from Am-
en Laboratories) (10 g/kg for 7 days, from day 3 before to day
after the operation; G-CSF group), and 6 received no G-CSF
control group).
urgical Techniques
n all animals general anesthesia was induced and maintained
y means of intravenous injection of propofol, 20 mg/kg, and
ufentanil, 1 g/kg. All animals were operated on by the same
eam of surgeons (AV and FJ). The descending aorta was
xposed through a left anterolateral thoracotomy, entering the
hest through the fourth intercostal space. The aorta was dis-
ected and exposed at the level of the isthmus. Two 4-0 mono-
lament purse strings were made on the aortic arch and distally
n the descending aorta (Prolene, Ethicon, Inc). Systemic an-
icoagulation was induced with heparin (200 UI/kg), and a
4-mm diameter pediatric gastric tube was implanted between
he aortic arch and the thoracic descending aorta as an aorti-
oaortic shunt. Then the aorta was crossclamped proximally
mmediately after the origin of the left subclavian artery and 15
m distally. The descending aorta was transected, and the
orcine aortic valve conduit was inserted with 2 end-to-end 4-0
onofilament running sutures. On completion of the operation,
eparin was reversed with protamine (200 UI/kg). The chest
as closed in layers, and a chest tube was inserted. The chest
ube was removed after extubation. Animals were then settled in
tandard conditions, with food and drink ad libitum. All animals
eceived 1000 mg of ceftriaxon and 500 mg of aspirin for the
rst postoperative week on a daily basis. For pain control,
uring the first 2 operative days, a transdermal fentanyl patch
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ETas applied on the chest. All the animals received humane care
n compliance with the “Guide for the Care and Use of Labo-
atory Animals” published by the National Institutes of Health
National Institutes of Health publication no. 85-23, revised
985).
alve Follow-up and Explantation Process
n each group euthanasia was performed in one lamb at 3, 6, and
weeks and in the remaining animals at 16 weeks after implan-
ation. Euthanasia was performed under the same protocol of
nalgesia and anesthetic procedures as for implantation. Before
ermination, heparin (300 UI/kg) was administrated, and an
ortography was realized in each animal after catheterization of
he femoral artery to detect graft abnormalities (thrombosis,
neurysm, and stenosis) and to measure the transvalvular gra-
ient. Grafts were explanted together with the descending tho-
acic aorta.
alve Analysis
xplanted valve conduits were grossly examined. Aneurysmal
ortic dilatation, thickness, and retraction of the cusps and the
resence of visible calcifications were reported. Then fragments
rom the grafted aortic wall and cusps were sampled for cytologic
Figure 1. Kinetics of white blood cell counts in lambs
(10 g/kg) for 7 days.nalysis of colonizing cells and histologic analysis. a
The Journal of ThoracicFor histology, samples were fixed in a buffered 4% formalde-
yde solution, dehydrated, and embedded in paraffin. Sections
6 m) were stained with hematoxylin, eosin, and safran and with
asson trichrome. For analysis of the intima/media ratio, com-
uted planimetry was realized through Perfect Image 7.10 software
Clara Vision). In addition, orcein staining for elastic fibers and
on Kossa staining for calcium were performed.
Immunostaining of the paraffin sections was done with mono-
lonal antibody to -actin (1:20, 1 night at 4°C) or with poly-
lonal antibody to VWF (1:500, 2 hours at room temperature;
AKO) and respective isotope-matched IgG control (Cymbus
iotechnology). The immunoreaction was detected with alka-
ine phosphatase for -actin and with Avidin Biotin performed
omplex peroxidase for VWF. The tissue sections were ana-
yzed by 2 independent observers (DC and BJ) who were
linded to the animal group allocation.
ytologic Analysis and Molecular Probes
or cell isolation, tissue samples were digested for 45 minutes at
7°C in a solution containing type I collagenase, elastase, and
oybean trypsin inhibitor. After addition of 30% fetal calf serum,
ytocentrifuged preparations were made and frozen at 70°C.
luorescence in situ hybridization was performed with a bacterial
subcutaneous injection of recombinant human G-CSFafterrtificial chromosome (BAC 31EA; a kind gift of Dr François
and Cardiovascular Surgery ● Volume 131, Number 4 845
P
J
s
m
l
m
fi
h
i
c
w
S
S
I
s
i
m
t
R
E
B
h
p
t
G
p
w
m
c
e
r
R
V
T
m
s
n
m
s
c
a
V
A
a
x
(
w
s
x
v
w
N
g
H
R
Evolving Technology Juthier et al
8
ETiumi, Institut National de Recherche Agronomique, Jouy en
osas, France) to detect the presence of cells of ovine origin in the
amples. The ovine pancentromeric probe was labeled in red by
eans of nick-translation (Spectrum Red dUTP and Nick Trans-
ation Reagent kit, Vysis Inc). The slides were fixed, treated with
ild pepsin solution, and dehydrated. After denaturation, identi-
cation of the centromers was performed by means pf overnight
ybridization at 37°C. After washing, DNA was counterstained
n blue with 4=,6 diamino-2-phenylindole. A red labeling of the
hromosomes was observed in all ovine cells, and no labeling
as observed in porcine cells.
tatistical Analysis
tatistical analysis was performed with Statview software (SAS
nstitute Inc). Continuous variables were expressed as means 
tandard deviations. The Wilcoxon test was used to compare
ndividual blood cell values over the time course of the experi-
ents. The Kruskall-Wallis test was used to analyze differences in
he intima/media ratio among the 3 groups.
esults
ffects of G-CSF on Lamb White Blood Cell Counts
ecause the effects of recombinant human G-CSF in lambs
ad not been reported yet, we first tested the kinetics of
eripheral white blood cell counts after G-CSF administra-
ion in 4 lambs. A daily subcutaneous injection of 10 g/kg
-CSF was performed for 7 days, and blood sampling was
erformed every 2 days. An increase in all white cell counts
as observed as soon as 2 days after injection and was
aximal at day 7 (Figure 1). The mean counts of leuko-ytes, granulocytes, monocytes, and lymphocytes at day 7 w
46 The Journal of Thoracic and Cardiovascular Surgery ● Aprixceeded baseline values by 5-, 8.6-, 4.6-, and 2.6-fold,
espectively (P  .04).
esults of the Decellularization Process on Aortic
alve Conduits
he decellularization process did not induce macroscopic
odifications of the valve conduits. Histologic analysis
howed no remaining cells in the cusps and rare pyknotic
ucleus in the deepest part of the media and in the boarding
yocardial tissue. The organization of collagen fibers was
imilar to that of a native valve conduit (Figure 2). Valve
onduits were equally decellularized in the control group
nd in the G-CSF group before implantation.
alve Follow-up and Outcome
ngiography showed no aneurysmal dilatation or stenosis at
ny time in all 3 groups, except in one animal in the
enograft group that exhibited valve thrombosis at 6 weeks
Figure 3). In all other cases, no hemodynamic abnormality
as observed. In particular, no transvalvular gradient or
ystemic hypertension was observed in any animal. In the
enograft and the G-CSF groups, gross observation of the
alves showed calcifications of the leaflets and of the aortic
all, leaflet thickening, and shrinkage at 6, 8, and 16 weeks.
one of these lesions were observed in the decellularized
roup (Figure 4).
istologic and Cytologic Analysis
epresentative histologic features of the 3 groups at 16
Figure 2. Results of the decellularization pro-
cess (hematoxylin, eosin, and safran stain-
ing). Before and after decellularization: A,
native valve conduit; B, leaflet. A complete
decellularization of the aortic wall and of the
leaflets without destruction of the fibrous
structure is shown.eeks are shown in Figures 5 and 6 (top row, control group;
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ETiddle row, G-CSF group; and bottom row, xenograft group).
n the control group inflammatory cell infiltration and few
mall vessels were observed in the adventitia after 3 weeks
ut remained limited and did not increase during follow-up
Figure 5, A and B). A progressive neointimal thickening
ppeared after 6 weeks and increased up to 16 weeks
Figure 5, C). -Actin staining showed numerous positive
ells in the neointima (Figure 5, D). No cell was visible in
he media at any time. No modification of the elastic fibers
as observed (orcein staining; Figure 6, A). Rare microcal-
ifications appeared after 16 weeks in the junction between
dventitia and media (Von Kossa staining; Figure 6, B). A
ontinuous endothelial layer was seen on the luminal sur-
ace after 6 weeks and up to 16 weeks on the aortic wall and
he leaflets (VWF staining; Figure 6, C). Few cells were
bserved in the leaflets (Figure 6, D), some of them being
ositive for -actin staining.
In the G-CSF group a progressive inflammatory infiltra-
ion appeared in the adventitia at 3 weeks, which increased
ith time and was associated with the development of
Figure 3. A and B, Representative aspects of normal a
graft in the thoracic descending aorta (B). C and D, Spe
(C) and of the explanted valve (D) in the animal that
Arrows indicate site of the graft implantation.umerous neovessels at 16 weeks (Figure 5, A and B) and of o
The Journal of Thoracicmarked neointimal proliferation of -actin–positive cells
Figure 5, C and D). Necrotic zones were visible in the
edia, which remained acellular. Elastic fibers exhibited a
rogressive disorganization, thickening, and fragmentation
orcein staining; Figure 6, A). Von Kossa staining showed
icrocalcifications in the aortic wall and in the leaflets after
weeks. Elastic fiber disorganization and heavy calcifica-
ions at the adventitia-media and the media-neointima junc-
ions were observed (Figure 6, B). VWF staining showed
nly a discontinuous endothelial cell layer on the luminal
urface (Figure 6, C). Necrosis and inflammatory infiltration
as also visible in the leaflets associated with calcifications
Figure 6, D).
In the xenograft group a marked inflammatory infiltra-
ion and neovascularization was observed in the adventitia
s soon as after 3 weeks and increased up to 16 weeks
Figure 5, A and B). Calcifications were visible as soon as 6
eeks. At 16 weeks, the aortic wall and leaflets exhibited
eatures similar to those of the G-CSF group, with marked
eointimal thickening (Figure 5, C and D), disorganization
raphy (A) at 16 weeks and perioperative aspect of the
aspect of the 16 weeks after implantation aortography
rwent complete valve thrombosis (xenograft group).ortog
cific
undef elastic fibers (Figure 6, A), calcifications both in the
and Cardiovascular Surgery ● Volume 131, Number 4 847
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ETortic wall and the leaflets (Figure 6, B and D), and discon-
inuous endothelialization (Figure 6, C).
Comparison of the neointima/media thickness showed
hat the intima/media ratio increased continuously with time
n the 3 groups. This increase was more rapid and pro-
ounced in the xenograft group and the G-CSF group than
n the decellularized group at 3 weeks (Figure 7). However,
t 16 weeks, the intima/media ratio tended to be the same in
he 3 groups.
All the cells eluted from the grafted decellularized valves
ere stained by the centromeric probe, demonstrating their
utologous ovine origin (Figure 8).
iscussion
n this study decellularized porcine valve scaffolds im-
lanted in juvenile sheep exhibited good mechanical resis-
ance under high systemic strain after 16 weeks and were
artially recolonized by ovine cells in the leaflets and the
ortic wall. The healing process led to the formation of a
eointimal proliferation generated by ovine smooth muscle
ells. Treatment with G-CSF did not improve scaffold re-
olonization but rather induced accelerated deterioration of
he valve, which was similar to the xenograft rejection
rocess observed in nondecellularized porcine valves.
As a biologic extracellular matrix scaffold, we chose
orcine heart valves for their well-known good hemody-
amic behavior and unlimited availability. When used as
alve prostheses, these porcine scaffolds are usually treated
Figure 4. Macroscopic examination at 16 weeks. A,
xenograft and the G-CSF groups, but not in the contr
leaflets and of the aortic wall, leaflet thickening, andith glutaraldehyde to improve mechanical properties and w
48 The Journal of Thoracic and Cardiovascular Surgery ● Aprio limit the xenogeneic rejection process. However, glutar-
ldehyde treatment profoundly modifies the extracellular
atrix structure and makes it improper to support cell migra-
ion, recolonization, and the matrix-renewing process.14 De-
ellularization of porcine valves is another approach to limit
ell-mediated xenograft rejection and potentially facilitate
ecolonization by interstitial cells. Several decellularization
rocesses have been described, leading to important differ-
nces in the efficiency of cell removal, long-term mechan-
cal properties, and xenoantigen residual exposition.15,16 It
s noteworthy that in a series of 4 young patients, enzymatic
ecellularization of porcine grafts have shown severe draw-
acks associated with catastrophic clinical results, such as
apid graft failure, that were responsible for the death of
 w o thirds of the patients.17,18 By contrast, homografts
ecellularized with the same enzymatic process (Synergraft,
ryolife Inc) and implanted in adults have shown better
utcome.19 Furthermore, the postmortem analysis of a
ynergraft-treated homograft explanted 5 weeks after im-
lantation in a 60-year-old patient showed preserved morphol-
gy, although associated with inflammatory infiltration.20 In
ur study we used porcine xenografts decellularized through
nonenzymatic process on the basis of osmotic shock,
etergent cell extraction (0.1% sodium dodecylsulfate), and
ntiproteases recently described by Korossis and col-
eagues,12 which induced complete decellularization with-
ut major impairment of the structural proteins. Under that
rocess, valve conduit tissues had equal strength compared
ol group; B, G-CSF group; C, Xenograft group. In the
oup, gross observation showed calcifications of the
kage at 16 weeks.Contr
ol gr
shrinith fresh tissues and only modest changes in extensibility
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n vitro.13 In addition, this process was recently demon-
trated to remove xenoantigens.21 Using that protocol, we
bserved a complete tissue decellularization before implan-
ation, and this observation was further confirmed after
xplantation because all the cells eluted from the explanted
alves were positive for the ovine centromeric probe, dem-
nstrating their ovine origin.
Such decellularized scaffolds were recently demon-
trated in vitro to allow cell recolonization by smooth mus-
le cells without cytotoxicity.5 Our study analyzes for the
rst time the ability of this decellularized scaffold to be
ecolonized in vivo by nonporcine cells. Because high me-
hanical forces must be sustained by the aortic valve con-
Figure 5. Representative histologic aspects in the graft
group; middle row, G-CSF group; bottom row, xenograft
fibers and limited infiltration by inflammatory cells were
prominent in the G-CSF and xenograft groups than
neovascularization (arrows) was limited in the control
(Masson trichrome staining), Neointimal proliferation
groups than in the control group. D (anti--actin stain
layer in the 3 groups.uit, we implanted the scaffolds in the descending aorta of f
The Journal of Thoracicambs to evaluate its resistance to physiologic strains in
ivo. As previously reported by Korossis and colleagues12
n vitro, we observed that these scaffolds have a good
echanical resistance in vivo, with no aneurysm formation
nd no rupture. We chose, in this study, to implant the
orcine scaffolds in the descending aorta of lambs, where
ystemic strains are very high. Such an implantation site
llows us to test the aortic root resistance to high mechan-
cal strains but does not allow evaluation of the aortic leaflet
unctions.
We observed a limited recolonization associated with
eak inflammatory reaction, no visible calcifications, and
elayed neointimal proliferation, suggesting that this scaf-
rtic wall at 16 weeks in the 3 groups (top row, control
p). A, Adventitia (Masson trichrome staining): collagen
ble in the control group. Inflammatory cells were more
e control group. B (anti-VWF antibody), Adventitial
p and abundant in the G-CSF and xenograft groups. C
ed to be more important in the G-CSF and xenograft
Evidence of strong -actin staining in the neointimaled ao
grou
visi
in th
grou
tend
ing),old could be suitable for in vivo homing. Whether these
and Cardiovascular Surgery ● Volume 131, Number 4 849
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ET
ells can produce collagen to repair the valve remains to be
nvestigated. Moreover, the media of the aortic wall re-
ained acellular, and although delayed, neointimal prolif-
ration was comparable with that of nondecellularized
rafts after 16 weeks.
In an attempt to optimize scaffold recolonization, a
roup of lambs received G-CSF, a growth factor rou-
inely used in human clinical applications, which can
obilize multipotent progenitor cells from BM into pe-
ipheral blood. In myocardial infarction beneficial effects
f G-CSF, such as decreased left ventricular remodeling
nd improved myocardial function, have been obtained in
nimal models.22-24 The advocated mechanisms for these
Figure 6. Orcein, von Kossa, and immunochemical stai
tative aspects of the leaflets are shown (top row, cont
group). A (orcein staining), Elastic fibers remained
disorganized in the xenograft and G-CSF groups. B (Vo
aortic wall in the G-CSF and xenograft groups and no
surface of the aortic wall was covered by a continuou
disrupted layer (arrows) in the G-CSF and xenograft gro
of the leaflets in the 3 groups, with calcifications in theneficial effects are improvement of the postinfarct n
50 The Journal of Thoracic and Cardiovascular Surgery ● Apriealing process through increased macrophage infiltra-
ion, promotion of reparative collagen synthesis in the
nfarct area, inhibition of apoptosis, and increased neo-
ascularization.25 G-CSF has also been demonstrated to
mprove endothelialization of vascular grafts in dogs,26
uggesting that it could mobilize early progenitors for
ndothelial cells. Moreover, it was recently demonstrated
hat G-CSF mobilizes functional endothelial progenitor
ells in patients with coronary disease.27
Because human G-CSF had not been tested previously in
ambs, we first verified that it could induce a significant
ncrease in peripheral white blood cell counts in our model.
he observed increase was significant, although less pro-
with anti-VWF antibody in the 3 groups and represen-
oup; middle row, G-CSF group; bottom row, xenograft
llel in the control group and were disrupted and
ssa staining), Evidence of heavy calcifications in the
he control group. C (anti-VWF antibody), The luminal
yer of endothelial cells in the control group and by a
D (Masson trichrome staining), Representative aspects
CSF and xenograft groups.ning
rol gr
para
n Ko
t in t
s la
ups.
e G-ounced than in human subjects.28 Unfortunately, immuno-
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ETogic identification of stem cells was not possible in this
odel because available human antibodies against human
r mouse stem cell antigens do not react with sheep stem
ells. In grafted decellularized heart valves, G-CSF induced
n increase in inflammatory cell infiltration and neovessel
ormation in the adventitia, myointimal proliferation, and
alcifications, both in leaflets and the aortic wall, indicating
eleterious effects on valve outcome.
Several mechanisms could account for these observa-
ions. G-CSF is a physiologic component of the acute-
hase response, and its primary effect is the mobilization
f neutrophil granulocytes.29 G-CSF–mobilized cells also
ontain a significantly higher proportion of monocytes
han normal peripheral blood and of accessory cells,
articularly T-cell subsets. Therefore G-CSF can mobi-
ize various subsets of mature effector cells of the im-
une and inflammatory response, which could amplify
he immune and inflammatory reaction against residual
xtracellular matrix antigens of the decellularized scaf-
old. Although the decellularization process we used has
een shown to be the most effective on xenoantigen
emoval,21 recent data indicate that porcine scaffolds
ecellularized with a similar method keep a significant
otential to attract monocytes and promote their migra-
ion in extracellular matrix.16 Therefore the deleterious
igure 7. Time course of the intima/media ratio in the 3 groups.
Figure 8. Results of fluorescence in situ hybridization
ovine blood (B), and a negative control on porcine blood (C
The Journal of Thoracicffects of G-CSF could be related to a dramatic increase
f leukocyte-mediated immune and inflammatory reac-
ion against residual xenoantigens, as observed in non-
ecellularized xenografts. Decellularized allogeneic
alves could provide more adequate scaffolds for autol-
gous recellularization, as recently demonstrated.16 The
ffects of G-CSF on such allogeneic scaffolds remain to
e investigated.
It is noteworthy that the deleterious effects of G-CSF
ave recently been described in a clinical assay in myo-
ardial infarction in human subjects, in whom G-CSF
reatment resulted in increased restenosis rates after cor-
nary stenting.30 We also observed an increased myointi-
al proliferation in the grafted aortic wall, as well as
ncreased neovessel formation in the adventitia, indicat-
ng that G-CSF induces significant and potentially dele-
erious effects in the aortic wall remodeling process.
lthough we did not observe any aneurysmal formation,
uch an early inflammatory reaction could lead to signif-
cant weakening of the valve prosthesis and to acceler-
ted valve failure.
The immature sheep model has been used for years for
esting bioprosthetic tissue, which degenerates rapidly, as
n young patients, with morphology similar to that seen in
linical specimen. Although porcine valve scaffolds de-
ellularized through a nonenzymatic method underwent
elatively safe outcome, the extrapolation of data from
ny animal model to human valve implantation requires
aution. Human applications will require additional long-
erm data because previous results of implantation of
issue-engineered porcine heart valves in pediatric pa-
ients have been catastrophic.18 Further studies will be
equired.
In conclusion, we demonstrate that xenogeneic por-
ine heart valves decellularized through a nonenzymatic
rocess allow partial spontaneous autologous recoloniza-
ion, with delayed and limited inflammation and calcifi-
ations. However, the recolonization process remains
e cells eluted from the graft (A), a positive control onon th
).
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ETimited, suggesting that further improvement of the ex-
racellular scaffold is mandatory before human implan-
ation. In this setting G-CSF accelerated valve deteriora-
ion through increased inflammatory reaction and
alcifications. Further studies shouldconsider alternative
trategies to improve scaffold recolonization without in-
ucing adverse effects on valve outcome.
We thank François Piumi, Joris Andrieux, Christophe Roumier,
nd Valérie Soenen for their assistance in developing the ovine
olecular probe and Alexandre Eung for expert technical
ssistance.
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